Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Semjonow · SciRah

Researcher profile · Semantic Scholar

A. Semjonow

Share profile

A. Semjonow — researcher profile on SciRah

h-index: 37
Works: 208
Citations: 6,614

Most-cited papers

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.
T. Wiegel, D. Bartkowiak, D. Bottke, C. Bronner +17 more
2014European Urology432 citations
Semantic Scholar
Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
K. Rahbar, M. Weckesser, S. Huss, A. Semjonow +4 more
2016Journal of Nuclear Medicine151 citations Open access
Semantic Scholar
Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.
C. Stephan, S. Vincendeau, A. Houlgatte, H. Cammann +2 more
2013Clinical Chemistry143 citations Open access
Semantic Scholar
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.
C. Stephan, K. Jung, A. Semjonow, K. Schulze-Forster +6 more
2013Clinical Chemistry100 citations
Semantic Scholar
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings.
P. Chiu, C. Ng, A. Semjonow, Yao Zhu +19 more
2019European Urology98 citations
Semantic Scholar
Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.
T. Wiegel, D. Bartkowiak, D. Bottke, R. Thamm +15 more
2015International Journal of Radiation Oncology, Biology, Physics87 citations
Semantic Scholar
The percentage of prostate‐specific antigen (PSA) isoform [–2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men aged ≤65 years
M. Boegemann, C. Stephan, H. Cammann, S. Vincendeau +4 more
2016BJU International79 citations
Semantic Scholar
Complications after prostate biopsies in men on active surveillance and its effects on receiving further biopsies in the Prostate cancer Research International: Active Surveillance (PRIAS) study
Leonard P. Bokhorst, Inari Lepistö, Y. Kakehi, C. Bangma +9 more
2016BJU International69 citations
Semantic Scholar
Prospective randomized evaluation of risk-adapted prostate-specific antigen screening in young men: the PROBASE trial.
C. Arsov, N. Becker, B. Hadaschik, M. Hohenfellner +13 more
2013European Urology68 citations
Semantic Scholar
EGFR as a stable marker of prostate cancer dissemination to bones
P. Nastały, Sara Stoupiec, Marta Popęda, J. Smentoch +12 more
2020British Journal of Cancer56 citations Open access
Semantic Scholar
Diagnostic Classification of Cystoscopic Images Using Deep Convolutional Neural Networks.
Okyaz Eminaga, Nurettin Eminaga, A. Semjonow, B. Breil
2018JCO Clinical Cancer Informatics56 citations Open access
Semantic Scholar
Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer
Phillip Mikah, L. Krabbe, Okyaz Eminaga, E. Herrmann +5 more
2016BMC Cancer43 citations Open access
Semantic Scholar
Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study.
A. Westermann, D. Schmidt, S. Holdenrieder, R. Moritz +5 more
2014Anticancer Research43 citations
Semantic Scholar
Active surveillance for low-risk prostate cancer.
C. Bangma, M. Bul, T. van der Kwast, T. Pickles +19 more
2013Critical reviews in oncology/hematology39 citations
Semantic Scholar
The Role of the Neutrophil to Lymphocyte Ratio for Survival Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone
M. Boegemann, K. Schlack, Stefan Thomes, Julie Steinestel +5 more
2017International Journal of Molecular Sciences36 citations Open access
Semantic Scholar
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study.
H. Luiting, S. Remmers, E. Boevé, R. Valdagni +7 more
2022European Urology Oncology35 citations Open access
Semantic Scholar
Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index.
M. Roobol, M. Vedder, D. Nieboer, A. Houlgatte +8 more
2015European Urology Focus30 citations Open access
Semantic Scholar
The need for harmonized structured documentation and chances of secondary use - Results of a systematic analysis with automated form comparison for prostate and breast cancer
Rainer Krumm, A. Semjonow, J. Tio, H. Duhme +4 more
2014Journal of Biomedical Informatics27 citations Open access
Semantic Scholar
Genome-Wide Investigation of Multifocal and Unifocal Prostate Cancer—Are They Genetically Different?
C. Ibeawuchi, H. Schmidt, R. Voss, U. Titze +7 more
2013International Journal of Molecular Sciences25 citations Open access
Semantic Scholar
Influence of Statins on Survival Outcome in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Abiraterone Acetate
M. Boegemann, K. Schlack, A. Fischer, J. Gerss +4 more
2016PLoS ONE24 citations Open access
Semantic Scholar
PROPOSe: A Real-life Prospective Study of Proclarix, a Novel Blood-based Test to Support Challenging Biopsy Decision-making in Prostate Cancer.
T. Steuber, I. Heidegger, M. Kafka, M. A. Roeder +13 more
2021European Urology Oncology21 citations
Semantic Scholar
Discordant prostate specific antigen test results despite WHO assay standardization
M. Boegemann, C. Arsov, B. Hadaschik, K. Herkommer +5 more
2018International Journal of Biological Markers20 citations
Semantic Scholar
Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy
C. Ibeawuchi, H. Schmidt, R. Voss, U. Titze +7 more
2015International Journal of Molecular Sciences20 citations Open access
Semantic Scholar
HIS-based Kaplan-Meier plots - a single source approach for documenting and reusing routine survival information
B. Breil, A. Semjonow, C. Müller-Tidow, F. Fritz +1 more
2011BMC Medical Informatics Decis. Mak.19 citations Open access
Semantic Scholar
Combination possibility and deep learning model as clinical decision-aided approach for prostate cancer
Okyaz Eminaga, Omran Al-Hamad, M. Boegemann, B. Breil +1 more
2019Health Informatics Journal15 citations Open access
Semantic Scholar
ALDH1‐positive intratumoral stromal cells indicate differentiated epithelial‐like phenotype and good prognosis in prostate cancer
P. Nastały, M. Filipska, C. Morrissey, E. Eltze +4 more
2019Translational Research: The Journal of Laboratory and Clinical Medicine15 citations Open access
Semantic Scholar
GDF15 and Hepcidin as Prognostic Factors in Patients with Prostate Cancer
Franca Julia Winand, M. Boegemann, I. Gallitz, L. Hertle +5 more
201415 citations Open access
Semantic Scholar
The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
Okyaz Eminaga, Reemt Hinkelammert, U. Titze, M. Abbas +3 more
2014Urologic oncology14 citations
Semantic Scholar
Phase III results of adjuvant radiotherapy (RT) versus wait-and-see (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP)(ARO 96-02/AUO AP 09/95): Ten years follow-up.
T. Wiegel, D. Bottke, D. Bartkowiak, C. Bronner +16 more
2013Journal of Clinical Oncology13 citations
Semantic Scholar
Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy.
Okyaz Eminaga, M. Bögemann, B. Breil, U. Titze +4 more
2014Urologic oncology12 citations
Semantic Scholar
Artificial Intelligence-Based Prognostic Model for Urologic Cancers: A SEER-Based Study
Okyaz Eminaga, E. Shkolyar, B. Breil, A. Semjonow +4 more
2022Cancers11 citations Open access
Semantic Scholar
ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis
K. Schlack, L. Krabbe, K. Rahbar, K. Isenberg +3 more
2021Translational Andrology and Urology11 citations Open access
Semantic Scholar
CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer
Okyaz Eminaga, M. Abbas, Reemt Hinkelammert, U. Titze +4 more
2012BMC Medical Informatics and Decision Making11 citations Open access
Semantic Scholar
Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer
A. Omari, P. Nastały, Sara Stoupiec, A. Bałabas +8 more
2018International Journal of Cancer10 citations Open access
Semantic Scholar
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer
K. Schlack, L. Krabbe, M. Fobker, A. Schrader +2 more
2016International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
High‐Grade Prostatic Intraepithelial Neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: Existence of HGPIN near prostate cancer
Okyaz Eminaga, Reemt Hinkelammert, M. Abbas, U. Titze +3 more
2013The Prostate10 citations
Semantic Scholar
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
P. Nastały, J. Smentoch, Marta Popęda, Emanuele Martini +11 more
2021Journal of Personalized Medicine9 citations Open access
Semantic Scholar
The Association of the Long Prostate Cancer Expressed PDE4D Transcripts to Poor Patient Outcome Depends on the Tumour's TMPRSS2-ERG Fusion Status
D. van Strijp, Christiane de Witz, B. Heitkötter, S. Huss +6 more
2019Prostate Cancer9 citations Open access
Semantic Scholar
Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy
J. Smentoch, J. Szade, A. Żaczek, E. Eltze +3 more
2019Cancers9 citations Open access
Semantic Scholar
Linkage of Data from Diverse Data Sources (LDS): A Data Combination Model Provides Clinical Data of Corresponding Specimens in Biobanking Information System
Okyaz Eminaga, E. Özgür, A. Semjonow, J. Herden +4 more
2013Journal of medical systems9 citations
Semantic Scholar
BRCAness in prostate cancer
N. Bednarz-Knoll, E. Eltze, A. Semjonow, B. Brandt
2019OncoTarget8 citations Open access
Semantic Scholar
The Prognostic PDE4D7 Score in a Diagnostic Biopsy Prostate Cancer Patient Cohort with Longitudinal Biological Outcomes
D. van Strijp, Christiane de Witz, P. Vos, E. den Biezen-Timmermans +12 more
2018Prostate Cancer8 citations Open access
Semantic Scholar
Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies
Okyaz Eminaga, Reemt Hinkelammert, M. Abbas, U. Titze +5 more
2015BJU International7 citations
Semantic Scholar
Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.
Reemt Hinkelammert, Okyaz Eminaga, O. Bettendorf, E. Eltze +3 more
2014Urologic oncology7 citations
Semantic Scholar
Decision aid and cost compensation influence uptake of PSA-based early detection without affecting decisional conflict: a cluster randomised trial
D. Tiedje, M. Borowski, A. Simbrich, Kathrin Schlößler +15 more
2021Scientific Reports6 citations Open access
Semantic Scholar
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study.
A. Erickson, S. Luzzago, A. Semjonow, H. Vasarainen +5 more
2018European Urology Oncology6 citations
Semantic Scholar
Testosterone-Induced Prostate Growth Is Blocked by Co- and Preadministration of Norethisterone Enanthate in Castrated Cynomolgus Monkeys
J. Wistuba, E. Nieschlag, A. Semjonow, R. Sandhowe-Klaverkamp +4 more
2012Urologia internationalis6 citations
Semantic Scholar
Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer.
K. Besler, Aleksandra Węglarz, Laura Keller, G. von Amsberg +14 more
2022Clinical Chemistry5 citations Open access
Semantic Scholar
Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architecture
Okyaz Eminaga, A. Semjonow, E. Eltze, O. Bettendorf +5 more
2016Journal of Biomedical Informatics5 citations Open access
Semantic Scholar
An Electronic Specimen Collection Protocol Schema (eSCPS)
Okyaz Eminaga, A. Semjonow, E. Oezguer, J. Herden +4 more
2013Methods of Information in Medicine5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Eltze×16
Invite
E. Eltze — researcher profile on SciRah
Okyaz Eminaga×13
Invite
Okyaz Eminaga — researcher profile on SciRah
M. Boegemann×9
Invite
M. Boegemann — researcher profile on SciRah
B. Brandt×8
Invite
B. Brandt — researcher profile on SciRah

N. Bednarz-Knoll

×7

Invite

N. Bednarz-Knoll — researcher profile on SciRah

Invite

U. Titze — researcher profile on SciRah

Invite

M. Abbas — researcher profile on SciRah

O. Bettendorf×7

Invite

O. Bettendorf — researcher profile on SciRah

Invite

A. Schrader — researcher profile on SciRah

M. Bögemann×6

Invite

M. Bögemann — researcher profile on SciRah

Invite

B. Breil — researcher profile on SciRah

Reemt Hinkelammert×6

Invite

Reemt Hinkelammert — researcher profile on SciRah